Status:
COMPLETED
Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT
Lead Sponsor:
Military Institute od Medicine National Research Institute
Conditions:
Early Release of Chromogranin A (CgA)
Eligibility:
All Genders
18+ years
Brief Summary
The results of the study suggest that an early change in CgA levels might serve as a prognostic factor in NET patients treated with PRRT.
Eligibility Criteria
Inclusion
- confirmed NET
- peptide receptor radionuclide therapy (PRRT)
Exclusion
- lack of patient consent to a clinical trial
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06183047
Start Date
October 1 2016
End Date
September 30 2023
Last Update
December 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.